The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Alan Goforth is a freelance writer in suburban Kansas City. In addition to freelancing for several publications, he has written a dozen books about sports and other topics.
M&A activity among health care service providers likely will remain soft over the next 12 to 18 months, with only a modest rebound from recently depressed levels.
Last week, the Federal Trade Commission, Justice Department, and the Department of Health and Human Services launched an easily accessible online portal for the public to report health care practices that may harm competition.
After UnitedHealth was a no-show at the House hearing last week on the Change Healthcare cyberattack, UnitedHealth Group CEO Andrew Witty is now scheduled to testify before a House panel on May 1.
Because there currently is no standard fee schedule or uniform approach, calculating trauma activation fees is left to the discretion of each individual trauma center.
Last week, Pres. Biden released a draft of the new Secretary of Education plan that would cancel or reduce student loan debt for millions of borrowers, following the Supreme Court's rejection of his debt cancellation in 2023.
Since most retirees no longer have pensions, financial advisors need to advise employees to take some of their 401(k) assets and convert them into protected income earmarked for retirement days, says The Longevity Project.
During the first congressional hearing on the Change Healthcare cyberattack on Tuesday, lawmakers zeroed in on the 2022 merger of UnitedHealth and Change Healthcare, which some members said was a national security risk.
This week, the Biden administration unveiled the Global Health Security Strategy, which will work with 50 partner nations that include developing countries, such as Haiti and Bangladesh, to prevent future global pandemics.
A settlement between the drugmaker and insulin patients that would have capped patients' out-of-pocket insulin costs at $35 for 4 years has fallen apart, after an "unfavorable ruling" from the judge overseeing the case.